PATENT CLAIM ANALYSIS

Application Number: 16137493
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "182000"]

Abstract:
Provided is a pharmaceutical composition which contains fulvestrant in an amount of equal to or greater than 8% by mass with respect to the entire mass of the pharmaceutical composition, an aqueous solvent satisfying (1) to (4), and a pharmaceutically acceptable nonaqueous carrier satisfying (A) and (B). (1) Ethanol is contained in an amount of equal to or greater than 8% by mass with respect to the entire mass of the pharmaceutical composition. (2) At least one kind of polyhydric alcohol selected from propylene glycol or 1,3-butylene glycol is contained in an amount of equal to or greater than 3% by mass with respect to the entire mass of the pharmaceutical composition. (3) A content of benzyl alcohol is less than 5% by mass with respect to the entire mass of the pharmaceutical composition. (4) A content of the aqueous solvent is 15% to 50% by mass with respect to the entire mass of the pharmaceutical composition. (A) A content of benzyl benzoate is less than 1% by mass with respect to the entire mass of the pharmaceutical composition. (B) A content of the nonaqueous carrier is 40% to 75% by mass with respect to the entire mass of the pharmaceutical composition.

Claim (Index 10):
A pharmaceutical composition comprising:\n fulvestrant; an aqueous solvent; and a pharmaceutically acceptable nonaqueous carrier, wherein a content of the fulvestrant is equal to or greater than 8% by mass with respect to the entire mass of the pharmaceutical composition, the aqueous solvent satisfies the following requirements (i) to (iv), and the pharmaceutically acceptable nonaqueous carrier satisfies the following requirements (a) to (d). (i) ethanol is contained in an amount of 10% by mass to 20% by mass with respect to the entire mass of the pharmaceutical composition (ii) propylene glycol is contained in an amount of 10% by mass to 20% by mass with respect to the entire mass of the pharmaceutical composition (iii) a content of benzyl alcohol is less than 5% by mass with respect to the entire mass of the pharmaceutical composition (iv) a content of the aqueous solvent is 20% by mass to 40% by mass with respect to the entire mass of the pharmaceutical composition (a) a content of benzyl benzoate is less than 1% by mass with respect to the entire mass of the pharmaceutical composition (b) castor oil is contained in an amount of equal to or greater than 40% by mass with respect to the entire mass of the pharmaceutical composition (c) a content of at least one kind of vegetable oil selected from sesame oil or peanut oil is less than 20% by mass with respect to the entire mass of the pharmaceutical composition (d) a content of the pharmaceutically acceptable nonaqueous carrier is 40% by mass to 75% by mass with respect to the entire mass of the pharmaceutical composition

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 3.69231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14117958', '14181244', '14996489', '15799281', '13255054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7534797769390742
- 35 USC 102 Novelty (BERT): 0.5016844260232076
- Combined Prediction Score: 0.7283002418474875
- Mean Citation Score: 217.697682
- Max Citation Score: 226.71384
- Similarity Product: 147.03375506446838

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test